The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease

European Respiratory Journal

Volumn 46, Issue 4, 2015, Pages 988-1000

  Gimeno Santos, Elena ^a,b,c,d   Raste, Yogini ^e   Demeyer, Heleen ^f   Louvaris, Zafeiris ^g   De Jong, Corina ^h   Rabinovich, Roberto A ⁱ   Hopkinson, Nicholas S ^e   Polkey, Michael I ^e   Vogiatzis, Ioannis ^g   Tabberer, Maggie ^j   Dobbels, Fabienne ^k   Ivanoff, Nathalie ^l   De Boer, Willem I ^m   Van Der Molen, Thys ^h   Kulich, Karoly ⁿ   Serra, Ignasi ^a,b,c   Basagaña, Xavier ^a,b,c   Troosters, Thierry ^f   Puhan, Milo A ^o   Karlsson, Niklas ^p   Garcia Aymerich, Judith ^a,b,c   Corriol Rohou, Solange ^p   Jarrod, Ian ^q   Erzen, Damijen ^r   Brindicci, Caterina ^s   Higenbottam, Tim ^s   Scuri, Mario ^s   McBride, Paul ^t   Kamel, Nadia ^u   De Boer, Pim ^v   Glendenning, Alastair ⁿ   Rudell, Katja ^w   Wilson, Frederick J ^w   Nikai, Enkeleida ^x   MacNee, Bill ^i,o   Frei, Anja ^o   more..

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d UNIVERSITAT RAMON LLULL   (Spain)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g Thorax Foundation   (Greece)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

^j GLAXOSMITHKLINE   (United Kingdom)

^k UNIVERSITY OF LEUVEN   (Belgium)

^l Almirall SA ^*  (Spain)

^m Lung Alliance Netherlands   (Netherlands)

ⁿ NOVARTIS PHARMA AG   (Switzerland)

^o UNIVERSITY OF ZURICH   (Switzerland)

^p ASTRAZENECA R AND D   (Sweden)

^q BRITISH LUNG FOUNDATION   (United Kingdom)

^r BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^s CHIESI FARMACEUTICI S P A   (Italy)

^t Choice Healthcare Solutions   (United Kingdom)

^u European Respiratory Society   (Switzerland)

^v Netherlands Asthma Foundation   (Netherlands)

^w Pfizer Walton Oaks   (United Kingdom)

^x UCB PHARMA   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CONFERENCE PAPER; CONSTRUCT VALIDITY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSESSMENT; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROACTIVE PHYSICAL ACTIVITY IN COPD INSTRUMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TEST RETEST RELIABILITY; VALIDATION PROCESS; ALGORITHM; CLINICAL TRIAL; EUROPE; FACTOR ANALYSIS; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOMETRY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

AGED; ALGORITHMS; CROSS-OVER STUDIES; EUROPE; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; PSYCHOMETRICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84943274623     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00183014     Document Type: Conference Paper

References (35)

1. Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1435-1445.
2. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61: 772-778.
3. Garcia-Aymerich J, Lange P, Serra I, et al. Time-dependent confounding in the study of the effects of regular physical activity in chronic obstructive pulmonary disease: an application of the marginal structural model. Ann Epidemiol 2008; 18: 775-783.
4. Vorrink SNW, Kort HSM, Troosters T, et al. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res 2011; 12: 33-40.
5. Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012; 40: 1115-1122.
6. Troosters T, Sciurba F, Battaglia S, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med 2010; 104: 1005-1011.
7. Pitta F, Troosters T, Spruit M, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 972-977.
8. Giacomini M, DeJean D, Simeonov D, et al. Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature. Ont Health Technol Assess Ser 2012; 12: 1-47.
9. Gimeno-Santos E, Frei A, Steurer-Stey C, et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax 2014; 69: 731-739.
10. Van Remoortel H, Giavedoni S, Raste Y, et al. Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Act 2012; 84-106.
11. Dobbels F, de Jong C, Drost E, et al. The PROactive innovative conceptual framework on physical activity. Eur Respir J 2014; 44: 1223-1233.
12. Williams K, Frei A, Vetsch A, et al. Patient-reported physical activity questionnaires: a systematic review of content and format. Health Qual Life Outcomes 2012; 10: 28-45.
13. Gimeno-Santos E, Frei A, Dobbels F, et al. Validity of instruments to measure physical activity may be questionable due to a lack of conceptual frameworks: a systematic review. Health Qual Life Outcomes 2011; 9: 86-99.
14. US Department of Health and Human Services Food and Drug Administration. Guidance for Industry. Patient-Reported Outcomes Measures: Use in Medical Product Development to Support Labeling Claims. 2009. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf Date last accessed: July 26, 2014.
15. Rabinovich RA, Louvaris Z, Raste Y, et al. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 2013; 42: 1205-1215.
16. Van Remoortel H, Raste Y, Louvaris Z, et al. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One 2012; 7: e39198.
17. Committee for Medicinal Products for Human Use, European Medicines Agency. Qualification of Novel Methodologies for Drug Development: Guidance to Applicants. 2008. www.ema.europa.eu/docs/en-GB/document-library/Regulatory-and-procedural-guideline/2009/10/WC500004201.pdf Date last accessed: July 26, 2014.
18. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-654.
19. Jones PW, Chen W-H, Wilcox TK, et al. Characterizing and quantifying the symptomatic features of COPD exacerbations. Chest 2011; 139: 1388-1394.
20. Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care 2007; 45: S22-S31.
21. Andrich D. A rating formulation for ordered response categories. Psychometrika 1978; 43: 561-573.
22. Meguro M, Barley EA, Spencer S, et al. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest 2007; 132: 456-463.
23. Pesudovs K, Burr JM, Harley C, et al. The development, assessment, and selection of questionnaires. Optom Vis Sci 2007; 84: 663-674.
24. Crane PK, Gibbons LE, Jolley L, et al. Differential item functioning analysis with ordinal logistic regression techniques. DIFdetect and difwithpar. Med Care 2006; 44: S115-S123.
25. Choi SW, Gibbons LE, Crane PK. lordif: an R package for detecting differential item functioning using iterative hybrid ordinal logistic regression/item response theory and Monte Carlo simulations. J Stat Softw 2011; 39: 1-30.
26. Hill CD, Edwards MC, Thissen D, et al. Practical issues in the application of item response theory: a demonstration using items from the pediatric quality of life (PedsQL) 4.0 generic core scales. Med Care 2007; 45: S39-S47.
27. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician 1983; 32: 307-317.
28. Troosters T, Sciurba FC, Decramer M, et al. Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial. NPJ Prim Care Respir Med 2014; 24: 14003.
29. Hataji O, Naito M, Ito K, et al. Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2013; 8: 1-5.
30. O'Donnell DE, Casaburi R, Vincken W, et al. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med 2011; 105: 1030-1036.
31. Donaire-Gonzalez D, Gimeno-Santos E, Serra I, et al. Validación del cuestionario de actividad física de Yale en pacientes con enfermedad pulmonar obstructiva crónica. [Validation of the Yale Physical Activity Survey in chronic obstructive pulmonary disease patients.] Arch Bronconeumol 2011; 47: 552-560.
32. Frost MH, Reeve BB, Liepa AM, et al. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health 2007; 10: Suppl. 2, S94-S105.
33. Snyder CF, Watson ME, Jackson JD, et al. Patient-reported outcome instrument selection: designing a measurement strategy. Value Health 2007; 10: Suppl. 2, S76-S85.
34. Turner RR, Quittner AL, Parasuraman BM, et al. Patient-reported outcomes: instrument development and selection issues. Value Health 2007; 10: Suppl. 2, S86-S93.
35. Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007; 10: Suppl. 2, S125-S137.